http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120111886-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd7c27b9ec61781656e6f039702fd568 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
| filingDate | 2011-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78a66fd18f49ad1a2ba2d1bd42b5537e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e80b93572da049d3dd85baec8eefdaf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eec90cfe6c98d15b0df154b5f968533c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79ee2febeeb18fc7c5403ad005f9b369 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18b464ee28e830654c546a16b4e73067 |
| publicationDate | 2012-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120111886-A |
| titleOfInvention | Novel chromene derivatives, pharmaceutically acceptable salts or isomers thereof, preparation methods thereof, and pharmaceutical compositions for the prevention or treatment of PRA-1 related diseases comprising the same |
| abstract | The present invention relates to novel chromate derivatives, thrombin receptor antagonists, pharmaceutically acceptable salts or isomers thereof, methods for preparing the same, and pharmaceutical compositions for the prevention or treatment of PRA-related diseases including the same. Since the chromium derivative of the present invention exhibits an excellent PAR-1 antagonistic effect, the pharmaceutical composition for preventing or treating PAR-1 related diseases, as an antagonist, coronary artery disease, thrombosis, cerebrovascular disease or arteriosclerosis, blood vessels It can be used for the prevention or treatment of thrombosis related diseases, inflammation or cancer, including cardiovascular diseases including restenosis, blood coagulation, hypertension, arrhythmia, angina pectoris, heart failure and the like. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210030540-A |
| priorityDate | 2011-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.